Prognosis - 1
Mean survival based on type of MDS:
Primary
MDS:
t-MDS:
70
months: and only 5-10% go to AML
1 –
6 years or more
10
months
50-80%
transform to AML
RA
Mean survival based on FAB classification of
MDS:
RARS
Normal karyotype, no neutropenia, and no thrombocytopenia
4-8
months: and 55% go to AML
RAEB
“POOR”
“GOOD”
CMML = fits into one
or the other by the number of blasts present.
RAEB-t